Location Biot, Provence-Alpes-Cote d'Azur, France Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
With over 25 years’ experience in gene therapy, immuno-virology and drug development, David specializes in scientific and medical projects in academic, biotech and industry settings. Prior to joining InnoSkel, he served as Vice-President, Translational Medicine at Asklepios Biopharmaceutical (AskBio) where he led the platforms and program resources
to marshal preclinical, INDs and early clinical programs. Prior to this, David was Director, HIV Biology, Drug Discovery For Immune Therapy And Cure at GlaxoSmithKline where he was responsible for building an immunotherapy and curative portfolio and modernizing the strategic pipeline.
As CSO, David is responsible for overseeing InnoSkel’s research and development strategy and operations as the Company progresses its platform for rare skeletal disorders.
